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The Editorial on the Research Topic 
Exploring Gender and Sex Differences in Behavioral Dyscontrol: From Drug Addiction to 
Impulse Control Disorders
This Research Topic gathers animal and human research articles, reviews, and opinion articles 
on current research in the field of sex and gender differences in behavioral addictions, which are 
complex disorders with interacting factors, including environmental factors, comorbidity, and per-
sonality traits (1, 2). Research in this field adds to the long-held argument that male and female brains 
do differ. However, while evidence exists on how male and female brains functionally differ (3–5), 
conflicting findings suggest that human brains cannot be narrowly classified into sexes/genders (6).
Over the past decade, there have been major advances in our understanding of sex and gender 
differences in behavioral addictions and underlying motivations (7, 8), brain reward processes (9), 
and impulsive behaviors (10). Potential factors, which could provide a neurobiological basis for 
sex- and gender-based differences in behavioral addictions, have been identified. Among them, 
there are organizational and activational effects of gonadal hormones, socio-cultural factors, dif-
ferent impulse-control ability, and responsiveness to stress (11, 12). It is important to note that, 
although often used as synonymous, the terms “sex” and “gender” are not interchangeable. In fact, 
the term “sex” is referred to biological attributes and characteristics associated with the adjectives 
“male” and “female” (i.e., anatomy and physiology inherent male-female differences), while “gender” 
concerns sociocultural distinctions between males and females (i.e., culture-related dogmas and 
roles, behaviors embraced by men and women that shape their daily life and activities).
In this Research Topic, basic researchers and clinicians that are leading experts in the field provide 
original findings and overviews on the role of sex and gender in modulating addictive behaviors 
and developing behavioral addictions. First, sex and gender differences in addiction to cannabis, 
methamphetamine, cocaine, and alcohol are discussed. Rubino and Parolaro systematically reviewed 
human and animal studies showing how males and females respond differently to cannabinoid com-
pounds. In particular, dichotomy in the pharmacokinetics of THC observed in males and females may 
contribute to their dissimilar responses to cannabinoids. The role of sexual dimorphism in the brain 
endocannabinoid system and its interaction with gonadal hormones may also play a part (13–18). 
Accordingly, Ruda-Kucerova et al. presented evidence that sex-dependent differences exist in the 
reinstatement of methamphetamine-seeking behavior in abstinent rats. Notably, females displayed 
higher vulnerability to relapse to methamphetamine seeking independently of the current estrous 
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cycle phase, thus suggesting that central mechanisms responsible 
for the enhanced response displayed by females are not affected 
by circulating ovarian hormones.
In humans, sex and gender differences are reported in psy-
chiatric comorbidity and plasma biomarkers in abstinent cocaine 
addicts and in behavioral impulsivity in heavy alcohol drinkers. 
Specifically, Pedraz et  al. demonstrated that cocaine addicted 
men and women differ with regard to the levels of plasma 
biomarkers for cocaine addiction. Notably, while men exhibit a 
higher incidence of substances use comorbidity (e.g., alcohol), 
cocaine addicted women display a higher prevalence of comorbid 
psychiatric disorders (e.g., anxiety). In addition, Weafer et  al. 
demonstrated that heavy alcohol female drinkers show poorer 
inhibitory control than male drinkers do, although it remains to 
be determined whether the reported higher behavioral impulsiv-
ity in women is the cause or the consequence of heavy drinking. 
That behavioral control is impacted by sex and gender is further 
supported by evidence compellingly reviewed by Carroll and 
Smethells revealing sex- and gender-dependent differences in 
impulsivity, food, and drug addiction. Importantly, authors dis-
cussed pharmacological and behavioral treatments for improving 
control of impulses in a sex-tailored manner, an approach also 
suggested for drug and behavioral addictions (19, 20). Among 
behavioral addictions, sexual addiction (often referred to as 
compulsive sexual behavior) is discussed by Weinstein et al. who 
found that men are more likely to use cybersex and experience 
craving for pornography than women. Importantly, both craving 
for pornography and frequency of cybersex were associated with 
difficulty in forming intimate relationship. In another clinical set-
ting, Davis et al. used a moderator-mediation model to perform an 
elegant analysis of personality risk-factors and sex in moderating 
the relationship between ADHD symptomatology and addictive 
behaviors. According to their observations, no sex differences in 
personality risk for addiction or in the use of addictive behaviors 
were found in ADHD patients. A positive affective neuroendo-
crinology (PANE) approach to study the mechanisms of reward 
motivation and dysregulation is herein proposed by Welker 
et al., which investigated sources of potential sex differences in 
the hormonal mechanisms of behavioral dyscontrol. Finally, 
Mitchell and Potenza highlighted the importance of investigat-
ing the relationship between sexual hormones and impulsivity 
traits to disentangle sex and gender differences in impulse control 
and behavioral addictions. Equally, Mendrek et al. emphasize the 
need of considering sex and gender in neuroscience by focusing 
on psychiatric disorders, such as schizophrenia and drug addic-
tion, where research on such differences is still in its infancy.
We wish to thank all the Authors of this Research Topic for 
presenting and discussing their work and sharing their personal 
expertise and opinions on this emerging field. Moreover, we 
express gratitude to all reviewers that found time in their busy 
schedules to provide us with useful and constructive comments. 
We feel that research on factors and mechanisms allowing for 
the pursuit of drug and non-drug rewards is essential to deliver 
innovative gender-tailored treatments and to develop preventive 
strategies that may efficiently reduce in men and women the risk 
of becoming addicted to a substance or an activity. Improving our 
knowledge on sex and gender differences in drug addiction and 
reward processing will remarkably have therapeutic implications 
and help the development of sex-tailored, gender-sensitive treat-
ment interventions. Some evidence has been already provided. 
In fact, pharmacological treatments differently affect male and 
female addicts. That is, the long-acting injectable form of naltrex-
one was found to be efficacious for males but not for females (21). 
This finding was further supported by the observation that oral 
naltrexone lacked efficacy relative to placebo in alcoholic women 
(22). Conversely, a 16-week course of fluoxetine initiated 8 weeks 
pre-quit cigarette smoking (“sequential” fluoxetine) reduced pre-
quit depressive symptoms, withdrawal-relevant negative affect, 
and craving to smoke during a pre-quit period only in women 
(23). These and similar studies confirmed the importance of 
considering gender when examining treatment efficacy, and 
highlight the timeliness of this Research Topic.
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